Relmada appoints Michael Quirk as senior advisor for sepranolone program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. HOOD
8. DFTX
9. MU
10. IBM

Go back to Relmada appoints Michael Quirk as senior advisor for sepranolone program
(NASDAQ: RLMD) Delayed: 6.89 +0.16 (2.38%)
Previous Close $6.73    52 Week High $4.10 
Open $6.75    52 Week Low $0.87 
Day High $7.12    P/E N/A 
Day Low $6.62    EPS $0.00 
Volume 1,440,966